Table 4

HER2 status of primary and matched recurrent lesion by in-situ hybridization
PRIMARY RECURRENCE
Negative Negative Polysomic Low Amplified High Amplified
Negative 53 11 0 0
Negative Polysomic 9 6 0 0
Low Amplified 0 0 (2*) 2 5
High Amplified 1 0 1 26

The 2* cases which did not contain breast malignancy upon central review were excluded.

Chan et al.

Chan et al. BMC Cancer 2012 12:555   doi:10.1186/1471-2407-12-555

Open Data